These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6854582)
1. 6-Aryl-4,5-dihydro-3(2H)-pyridazinones. A new class of compounds with platelet aggregation inhibiting and hypotensive activities. Thyes M; Lehmann HD; Gries J; König H; Kretzschmar R; Kunze J; Lebkücher R; Lenke D J Med Chem; 1983 Jun; 26(6):800-7. PubMed ID: 6854582 [TBL] [Abstract][Full Text] [Related]
2. Conformationally restricted congeners of hypotensive and platelet aggregation inhibitors: 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones derived from 5H-indeno[1,2-c]pyridazine. Cignarella G; Barlocco D; Pinna GA; Loriga M; Tofanetti O; Germini M; Sala F J Med Chem; 1986 Nov; 29(11):2191-4. PubMed ID: 3783580 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities. Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341 [TBL] [Abstract][Full Text] [Related]
5. [Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones]. Jiang Q; Sun CS Yao Xue Xue Bao; 1990; 25(8):598-603. PubMed ID: 2082682 [TBL] [Abstract][Full Text] [Related]
6. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones]. Yao FM; Sun CS Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059 [TBL] [Abstract][Full Text] [Related]
7. Effects of 6-[p-(4-phenylacetylpiperazin-1-yl)phenyl]-4,5-dihydro-3(2H)pyridazinone (CCI 17810) and aspirin on platelet aggregation and adhesiveness. Griffett EM; Kinnon SM; Kumar A; Lecker D; Smith GM; Tomich EG Br J Pharmacol; 1981 Apr; 72(4):697-705. PubMed ID: 7284687 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive and antithrombotic activities of 6-(substituted phenyl)-5-hydroxymethyl-4,5-dihydro-3(2H)pyridazinones. Barlocco D; Martini A; Pinna GA; Curzu MM; Sala F; Germini M Farmaco Sci; 1987 Aug; 42(8):585-94. PubMed ID: 3666129 [TBL] [Abstract][Full Text] [Related]
9. Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors. Laguna R; Rodriguez-Liñares B; Cano E; Estevez I; Raviña E; Sotelo E Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1151-5. PubMed ID: 9246748 [TBL] [Abstract][Full Text] [Related]
10. Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions. Sotelo E; Fraiz N; Yáñez M; Terrades V; Laguna R; Cano E; Raviña E Bioorg Med Chem; 2002 Sep; 10(9):2873-82. PubMed ID: 12110307 [TBL] [Abstract][Full Text] [Related]
11. Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Coelho A; Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E Bioorg Med Chem Lett; 2004 Jan; 14(2):321-4. PubMed ID: 14698150 [TBL] [Abstract][Full Text] [Related]
12. Pyridazines. Part 31: synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones. Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1574-7. PubMed ID: 12499593 [TBL] [Abstract][Full Text] [Related]
13. 5-Acyl-6-aryl-4-nitro-3(2H)pyridazinones and related 4-amino compounds: synthesis and pharmacological evaluation. Dal Piaz V; Ciciani G; Turco G; Giovannoni MP; Miceli M; Pirisino R; Perretti M J Pharm Sci; 1991 Apr; 80(4):341-8. PubMed ID: 1865334 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of 6-(7-theophylline)-3(2H)-pyridazinone. Corsano S; Strappaghetti G; Ferrini R; Giglioli N Arch Pharm (Weinheim); 1991 Dec; 324(12):999-1001. PubMed ID: 1815486 [TBL] [Abstract][Full Text] [Related]
15. Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure. Sircar I; Steffen RP; Bobowski G; Burke SE; Newton RS; Weishaar RE; Bristol JA; Evans DB J Med Chem; 1989 Feb; 32(2):342-50. PubMed ID: 2536438 [TBL] [Abstract][Full Text] [Related]
16. 6-Phenyl-4,5-dihydro-3(2H)-pyridazinones. A series of hypotensive agents. Curran WV; Ross A J Med Chem; 1974 Mar; 17(3):273-81. PubMed ID: 4204335 [No Abstract] [Full Text] [Related]
17. Synthesis and pharmacological evaluation of 4a-methyl-4,4a,5,6-tetrahydrothieno[2,3-h]cinnolin-3(2H)-ones. Pinna GA; Salis E; Berta D; Gavini E; D'Amico M Farmaco; 1997 Jan; 52(1):29-33. PubMed ID: 9181678 [TBL] [Abstract][Full Text] [Related]
18. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities. Demirayak S; Karaburun AC; Beis R Eur J Med Chem; 2004 Dec; 39(12):1089-95. PubMed ID: 15571871 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of 4,4a,5,6-tetrahydro-7,8-disubstituted-benzo[h]cinnolin-3(2H)-ones. Pinna GA; Loriga M; Curzu MM; D'Amico M Farmaco; 1997 Jan; 52(1):25-8. PubMed ID: 9181677 [TBL] [Abstract][Full Text] [Related]
20. [Effects of 6-(alpha alpha-diphenylacetylpiperazinyl) phenyl-5-methyl-4,5-dihydro-3 (2H)-pyridazinone on rabbit platelet aggregation and TXB2, cAMP production]. Zeng GQ; Wang XS; Sun DX; Lin AY; Ji Y; Chu JX; Rui YC Yao Xue Xue Bao; 1993; 28(4):256-9. PubMed ID: 8213167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]